ROCHESTER, Minn., June 27, 2016 /PRNewswire/ -- Transplant Genomics Inc.® (TGI) is collaborating with the Mayo Clinic Center for Individualized Medicine to develop, validate and commercialize diagnostic tests enabling personalized immunosuppression for solid organ transplant recipients. This multiyear collaboration includes an assessment of TGI's TruGraf™ test for renal transplant monitoring, a Mayo Clinic investment in TGI, and the co-development of new tests and technologies for additional targets, including exploratory studies in heart and liver transplantation. Physicians and researchers are participating at Mayo Clinic campuses in Arizona, Florida and Rochester, Minnesota. Principal investigators include: Mark Stegall, M.D., Raymond Heilman, M.D., and Martin Mai, M.D., Mayo Clinic Transplant Center. "At Mayo, our research in this area is focused on improving long-term kidney graft survival, so that patients would lead healthier lives. Genomic analysis of blood can reveal early signs of rejection in transplanted kidneys. The potential clinical utility is to be able to monitor for rejection more frequently than is possible with surveillance biopsies and to individualize immunosuppression in transplant recipients," says Dr. Stegall. "TruGraf's ability to detect early transplant rejection in patients with stable kidney transplant function will provide physicians with a tool to help provide the appropriate levels of immunosuppressive therapy. Our first collaborative project together is a case study in individualized medicine in which TruGraf will be used to support decisions around personalized immunosuppression," says Roy First, M.D., chief medical officer, Transplant Genomics.
Iolaire, I believe that you are talking about Transplant Genomics. Mayo is working with them-and my daughter is part of the study using blood tests to correlate what they are seeing in kidney biopsies.
Quote from: Xplantdad on February 28, 2018, 12:35:02 PMIolaire, I believe that you are talking about Transplant Genomics. Mayo is working with them-and my daughter is part of the study using blood tests to correlate what they are seeing in kidney biopsies. Thanks I knew I was botching that reference. My doctor also mentioned Mayo Rochester in the context of doing biopsies.Everyone else thank you for your posts. I think its good to get this discussion out in its own thread so people can read about the dangers and benefits.
Karen, you know, I don't think I ever knew for sure why you had that biopsy in the first place, and so I incorrectly assumed that it was just because you were one year post tx and that's just what they did at your center. I had not realized that your creatinine had gone up and that was the rationale. Thanks for clearing that up!So, after the biopsy you were told that there was no signs of rejection or any other problem. Did your doc ever tell you why your creatinine was elevated?
Does Lynette function at all now that you have Rockette? I'm assuming that Rockette is on the opposite side of Lynette? I don't know how that all works, having two txed kidneys! Can you tell me?
Two hours of online reading yesterday and it appears that maybe all this means is that he will have to increase his prednisone to a ridiculously high level for one-two weeks then taper down again and have another biopsy to confirm he's better.
So a week of intravenous steroids
So my hope of no-one calling me with biopsy results was a good sign but it turned out that they see some scarring in my new kidney. I guess I should have bothered them for the results in May.